•
Dec 31, 2022

Omega Healthcare Q4 2022 Earnings Report

Omega Healthcare reported mixed results for Q4 2022, with a decrease in revenue offset by gains on asset sales.

Key Takeaways

Omega Healthcare Investors, Inc. reported a net income of $47 million for Q4 2022, an increase compared to the same period in 2021. However, total revenues decreased due to operator restructurings and asset sales. The company completed new investments and continued to work through operator restructurings.

Net income for the quarter was $47 million, or $0.19 per common share.

Adjusted Funds From Operations (AFFO) for the quarter was $177 million, or $0.73 per common share.

Completed $89 million in real estate acquisitions and funded $15 million in capital renovation and construction-in-progress projects.

Sold 33 facilities for $321 million in cash proceeds and $105 million in seller financing, generating a $180 million gain.

Total Revenue
$145M
Previous year: $250M
-42.0%
EPS
$0.73
Previous year: $0.77
-5.2%
Gross Profit
$140M
Previous year: $246M
-43.0%
Cash and Equivalents
$297M
Previous year: $20.5M
+1346.9%
Total Assets
$9.41B
Previous year: $9.64B
-2.4%

Omega Healthcare

Omega Healthcare

Omega Healthcare Revenue by Segment

Forward Guidance

Omega Healthcare's first quarter earnings are expected to be impacted by deferred rents associated with additional operator restructurings, which will result in a decline in earnings and a related increase in the dividend payout ratio. Operating performance is expected to improve as the year progresses and operator restructurings are completed. However, the risk of further operator issues remains due to facility occupancy and profitability still being meaningfully below pre-pandemic levels.

Positive Outlook

  • Portfolio occupancy continues to grow, albeit modestly, as the labor market gradually improves.
  • Many states have implemented much needed Medicaid reimbursement rate increases.
  • Skilled nursing industry is an integral part of the healthcare continuum and an important tool in the effort to meet increasing clinical needs at a manageable price.
  • The industry is well positioned to benefit from multi-decade demographic tailwinds.
  • Omega will continue to work with its operators to help them meet this increased demand.

Challenges Ahead

  • First quarter earnings will be further impacted by deferred rents associated with additional operator restructurings.
  • Expected decline in first quarter earnings and a related increase in the dividend payout ratio.
  • Risk of further operator issues remains.
  • Facility occupancy and profitability are still meaningfully below pre-pandemic levels.
  • Inflation is still at elevated levels which leads to a challenging cost environment for the industry.